Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

WILLIAM C CRAGUN

Allopathic & Osteopathic Physicians Dermatology

NPI
1578673166
CMS profile
253525
Location
SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$200,485.35

495 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 10 of 10; records 451–495 of 495 matching records. This page contains 45 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

WILLIAM C CRAGUN

NPI 1578673166 · CMS profile ID 253525

Allopathic & Osteopathic Physicians / Dermatology

SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 10 of 10; records 451–495 of 495 matching records. This page contains 45 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1578673166?year=2019&recipient=provider&page=10#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
WILLIAM C CRAGUN, NPI 1578673166, CMS profile ID 253525. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 10 of 10; records 451–495 of 495 matching records. This page contains 45 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1578673166?year=2019&recipient=provider&page=10#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). WILLIAM C CRAGUN, NPI 1578673166, CMS profile ID 253525. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 10 of 10; records 451–495 of 495 matching records. This page contains 45 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1578673166?year=2019&recipient=provider&page=10#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
WILLIAM C CRAGUN, NPI 1578673166, CMS profile ID 253525, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 10 of 10; records 451–495 of 495 matching records. This page contains 45 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1578673166?year=2019&recipient=provider&page=10#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

495 matching records · $200,485.35 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 495 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 451–495 of 495.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie, Inc. $2,375.0003/04/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804021 CMS
AbbVie, Inc. $55.9203/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804017 CMS
AbbVie, Inc. $3.7602/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804025 CMS
Mayne Pharma Inc. $16.2402/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 705493157 CMS
AbbVie, Inc. $107.7302/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804009 CMS
PFIZER INC. $18.0602/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671873187 CMS
Lilly USA, LLC $22.5702/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658206345 CMS
Lilly USA, LLC $85.8202/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658206347 CMS
Lilly USA, LLC $15.6602/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658216613 CMS
Lilly USA, LLC $15.7002/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658226729 CMS
AbbVie, Inc. $61.0002/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804011 CMS
Lilly USA, LLC $4,050.0002/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658223277 CMS
Mayne Pharma Inc. $7.1402/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 705493155 CMS
Almirall LLC $15.7502/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 676652063 CMS
Novartis Pharmaceuticals Corporation $8.0902/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659198377 CMS
STRATA Skin Sciences, Inc. $12.3902/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688707699 CMS
Regeneron Healthcare Solutions, Inc. $19.7702/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673364807 CMS
Lilly USA, LLC $253.4902/09/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658209983 CMS
Lilly USA, LLC $31.5002/09/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658223279 CMS
Lilly USA, LLC $331.2002/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658226725 CMS
Lilly USA, LLC $366.8002/07/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658226723 CMS
UCB, Inc. $9.3902/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688250553 CMS
UCB, Inc. $1.6802/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688344213 CMS
Novartis Pharmaceuticals Corporation $10.3502/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659198373 CMS
AbbVie, Inc. $3,750.0002/04/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804023 CMS
Mayne Pharma Inc. $21.8401/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 705493153 CMS
Novartis Pharmaceuticals Corporation $2.6601/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659198371 CMS
Regeneron Healthcare Solutions, Inc. $4.8801/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673364805 CMS
GENZYME CORPORATION $18.5301/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694271251 CMS
UCB, Inc. $14.1101/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688250089 CMS
AbbVie, Inc. $24.8701/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804005 CMS
AbbVie, Inc. $17.9601/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804007 CMS
LEO Pharma Inc. $18.4301/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 687256905 CMS
Janssen Biotech, Inc. $12.6701/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658383505 CMS
AbbVie, Inc. $65.6101/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804109 CMS
Mission Pharmacal Company $18.2901/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 625336747 CMS
Mayne Pharma Inc. $13.5701/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 705493151 CMS
Aclaris Therapeutics, Inc. $8.2001/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700980623 CMS
Regeneron Healthcare Solutions, Inc. $17.1601/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673364803 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $12.1901/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684573261 CMS
AbbVie, Inc. $85.8201/03/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804209 CMS
AbbVie, Inc. $4,687.5001/03/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804211 CMS
AbbVie, Inc. $14.7101/03/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804213 CMS
AbbVie, Inc. $59.1301/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647804215 CMS
Mayne Pharma Inc. $14.3801/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 705493149 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $200,485.35 495
PY2020 $149,939.12 263
PY2021 $209,949.84 402
PY2022 $336,762.97 558
PY2023 $377,785.67 538
PY2024 $434,510.52 632
PY2025 $443,474.67 655

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $45,889.12 9
PY2020 Principal investigator $63,108.02 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 SANOFI US SERVICES INC. $2,091.00 12/06/2021 Non-covered Recipient Entity
Dermatology San Antonio (Aka Stephen Miller MD PA)
A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable No dispute reported 06/30/2026 838656659
Principal investigator 1 SANOFI US SERVICES INC. $1,250.00 10/25/2021 Non-covered Recipient Entity
Dermatology San Antonio (Aka Stephen Miller MD PA)
A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable No dispute reported 06/30/2026 838656661
Principal investigator 1 SANOFI US SERVICES INC. $2,439.00 10/04/2021 Non-covered Recipient Entity
Dermatology San Antonio (Aka Stephen Miller MD PA)
A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable No dispute reported 06/30/2026 838656651
Principal investigator 1 SANOFI US SERVICES INC. $4,252.00 09/07/2021 Non-covered Recipient Entity
Dermatology San Antonio (Aka Stephen Miller MD PA)
A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable No dispute reported 06/30/2026 838656649
Principal investigator 1 SANOFI US SERVICES INC. $75.00 05/17/2021 Non-covered Recipient Entity
Dermatology San Antonio (Aka Stephen Miller MD PA)
A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable No dispute reported 06/30/2026 838656647
Principal investigator 1 SANOFI US SERVICES INC. $4,000.00 05/17/2021 Non-covered Recipient Entity
Dermatology San Antonio (Aka Stephen Miller MD PA)
A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable No dispute reported 06/30/2026 838656655
Principal investigator 1 SANOFI US SERVICES INC. $1,000.00 05/17/2021 Non-covered Recipient Entity
Dermatology San Antonio (Aka Stephen Miller MD PA)
A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable No dispute reported 06/30/2026 838656657
Principal investigator 1 SANOFI US SERVICES INC. $6,833.00 05/10/2021 Non-covered Recipient Entity
Dermatology San Antonio (Aka Stephen Miller MD PA)
A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable No dispute reported 06/30/2026 838656653
Principal investigator 1 Novartis Pharmaceuticals Corporation $23,949.12 01/01/2021 Non-covered Recipient Entity
DERMATOLOGY SAN ANTONIO
AN EXPLORATORY, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTER STUDY TO COMPARE SECUKINUMAB 300 MG WITH PLACEBO AFTER 16 WEEKS OF TREATMENT IN ADULTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS AND SUBCLINICAL ENTHESITIS MEASURED BY MUSCULOSKELETAL ULTRASOUND No dispute reported 06/30/2026 800629412